Author: Madhavan, Maya; AlOmair, Lamya Abdulaziz; KS, Deepthi; Mustafa, Sabeena
Title: Exploring peptide studies related to SARS-CoV to accelerate the development of novel therapeutic and prophylactic solutions against COVID-19 Cord-id: gxauv4my Document date: 2021_7_3
ID: gxauv4my
Snippet: Recent advances in peptide research revolutionized therapeutic discoveries for various infectious diseases. In view of the ongoing threat of the COVID-19 pandemic, there is an urgent need to develop potential therapeutic options. Intense and accomplishing research is being carried out to develop broad-spectrum vaccines and treatment options for corona viruses, due to the risk of recurrent infection by the existing strains or pandemic outbreaks by new mutant strains. Developing a novel medicine i
Document: Recent advances in peptide research revolutionized therapeutic discoveries for various infectious diseases. In view of the ongoing threat of the COVID-19 pandemic, there is an urgent need to develop potential therapeutic options. Intense and accomplishing research is being carried out to develop broad-spectrum vaccines and treatment options for corona viruses, due to the risk of recurrent infection by the existing strains or pandemic outbreaks by new mutant strains. Developing a novel medicine is costly and time consuming, which increases the value of repurposing existing therapies. Since, SARS-CoV-2 shares significant genomic homology with SARS-CoV, we have summarized various peptides identified against SARS-CoV using in silico and molecular studies and also the peptides effective against SARS-CoV-2. Dissecting the molecular mechanisms underlying viral infection could yield fundamental insights in the discovery of new antiviral agents, targeting viral proteins or host factors. We postulate that these peptides can serve as effective components for therapeutic options against SARS-CoV-2, supporting clinical scientists globally in selectively identifying and testing the therapeutic and prophylactic agents for COVID-19 treatment. In addition, we also summarized the latest updates on peptide therapeutics against SARS-CoV-2.
Search related documents:
Co phrase search for related documents- abstract title and low molecular weight: 1
- action mechanism and adaptive immune response: 1, 2, 3
- action mechanism and liver disease: 1, 2, 3, 4
- action mechanism and low concentration: 1, 2, 3, 4
- action mechanism and low effect: 1, 2, 3, 4, 5, 6, 7
- action mechanism and low molecular weight: 1, 2
- action mechanism and low toxicity: 1, 2, 3, 4, 5, 6, 7
- action mechanism and lung viral load: 1, 2, 3
- active site and low concentration: 1, 2
- active site and low effect: 1
- active site and low molecular weight: 1, 2, 3, 4
- active site and low toxicity: 1, 2
- adaptive immune response and liver disease: 1
- liver disease and low concentration: 1
- liver disease and low effect: 1
- liver disease and low molecular weight: 1, 2, 3
- liver disease and low toxicity: 1
- low effect and lung viral load: 1
Co phrase search for related documents, hyperlinks ordered by date